Hitched onto the acquisition wagon
Consumer genomics test provider Invitae is acquiring Ciitizen, a consumer health platform enabling patients to access and leverage their health records to find better treatment and trials. The $325M acquisition will create a patient-consented clinico-genomic data platform that empowers consumer decision-making and can be mined for clinical research and customer insights. The Ciitizen deal marks Invitae’s 14th acquisition over five years, continuing the company’s transformation from a hereditary genetic diagnostics business into a data-lined highway from the consumer to specialty care.
Deep insight and empowerment for individuals propelled Ciitizen’s growth, led by serial entrepreneur Anil Sethi. Will Sethi’s prior employer Apple see its broad-based approach to health records take off? Apple is banking that through integration with (currently) 700 hospitals and clinics and new sharing capabilities, they can avoid the fate of Microsoft and Google’s personal records foray.
Want to help turbocharge our growth and impact on healthcare enterprise innovation? Rock Health is hiring a Sales Operations Manager.
Check out the job description and apply!
Amazon’s Ambitious Plans To Bring In-Person Medical Care to 20+ US Cities
Amazon Care eyes home-care visits (a further foray into the complexity of care delivery) Business Insider
OptumHealth Launches Virtual LGBTQ Education Program For Providers
Partnership with OutCare promotes equitable, affirming, and supportive care Modern Healthcare
Can Digital Health Resuscitate Our Broken Care Delivery System?
Virtual care innovation that tackles the widespread and climbing provider shortage MedCity News
Whoop’s New Wearable Can Go On Your Wrist—Or In Your Clothes
A business model expansion into “smart clothing” Wired
- AI-powered orthodontics company InBrace lines up $102M
- Menstrual health and ovulation app Flo gets $50M
- At-home testing startup YourBio raises $21M
- Pediatric teletherapy provider DotCom Therapy closes $13M
- Digital therapeutic for cognitive impairment Neuroglee grabs $10M
- Fitness analytics software to reduce injury Zone7 nets $8.2M
- Mental health DTx for cancer patients Blue Note Therapeutics adds $5.2M